OHSU in the news

‘Microdosing’ allowed under Oregon’s new psilocybin program

The Lund Report January 18, 2023
An article from The Lund Report reports on Oregon’s newly finalized regulations for the controlled use of the mushroom psilocybin. Atheir Abbas M.D., Ph.D., discusses the medical concerns and gaps in research related to microdosing psilocybin: “Part of the issue is we don't really know…I would predict that psilocybin will be associated with heart disease in people that use it too much. But we don't know; no one has looked.”

OHSU participates in a trial for drug that could help prevent Alzheimer’s disease

KGW-TV January 18, 2023
Researchers at OHSU are contributing to an international clinical trial exploring possible treatments for Alzheimer’s, specifically focusing on earlier intervention. The AHEAD Study looks at the treatment of a drug called Lecanemab, which could delay memory decline before symptoms of the disease appear.

Immigrant, refugee resource fair scheduled for Jan. 28

Beaverton Valley Times January 16, 2023
The Beaverton Valley Times reports that OHSU and Lutheran Community Services Northwest are hosting a resource fair and cultural celebration on Jan. 28 in Beaverton to aid immigrants and refugees in the Portland area.

Safe staffing at the top of new ANA president's priority list

Health Leaders January 16, 2023
Jennifer Mensik Kennedy, Ph.D., M.B.A., RN, says her priorities as the new American Nurses Association president include safe staffing and fighting racism; about nurse staffing she says: “This has been an issue well beyond COVID. COVID exacerbated it and shined a light on some of these issues, but this has been going on for some time. We need to focus on solving this one because it has a lot of impact on patient safety. This has an impact for nurses staying in the workforce.”
See more stories